Alisa Lask Insider Profile

4 Followers
Alisa Lask, Director at Nephros, holds 48.63K shares in Nephros (Ticker: NEPH), holds 112.56K shares in RVL Pharmaceuticals (Ticker: RVLPQ).
tipranks
Alisa Lask

Alisa Lask
Nephros (NEPH)
Director

Not Ranked
Alisa Lask has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$79K
98.58%
1.42%
A breakdown of Alisa Lask's holdings

Insider Roles

Nephros
(NEPH)
Director
RVL Pharmaceuticals
(RVLPQ)
Director
Roles that Alisa Lask holds in companies

Most Profitable Insider Trade

Stock:
Nephros
(NEPH)
Rating:Informative Buy
Date:Sep 13, 2019 - Sep 13, 2020
Return:-9.20%
The most profitable trade made by Alisa Lask

Alisa Lask's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Nephros
Dec 15, 2023
Director
Uninformative Buy
$78.29K
RVL Pharmaceuticals
Aug 14, 2023
Director
Uninformative Sell
5.88K
$1.13K
List of latest transactions for each holding click on a transaction to see Alisa Lask's performance on stock

Alisa Lask insider profile FAQ

What is the percentage of profitable transactions made by Alisa Lask?
The percentage of profitable transactions made by Alisa Lask is ―.
    What is the average return per transaction made by Alisa Lask?
    The average return per transaction made by Alisa Lask is ―.
      What stocks does Alisa Lask hold?
      Alisa Lask holds: NEPH, RVLPQ stocks.
        What was Alisa Lask’s latest transaction?
        Alisa Lask latest transaction was an Uninformative Buy of ―.
          What was Alisa Lask's most profitable transaction?
          Alisa Lask’s most profitable transaction was an Informative Buy of NEPH stock on September 13, 2019. The return on the trade was -9.20%.
            What is Alisa Lask's role in Nephros?
            Alisa Lask's role in Nephros is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.